Treatment of lentigo maligna with imiquimod before staged excision

Dermatologic Surgery

Volumn 34, Issue 2, 2008, Pages 147-151

  Cotter, Murray A ^a   McKenna, Jeffrey K ^a   Bowen, Glen M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; TAZAROTENE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREAM; DRUG EFFICACY; DRUG RESPONSE; EXCISION; FEMALE; FOLLOW UP; GEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT LENTIGO; MINIMAL RESIDUAL DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN BIOPSY; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; MIDDLE AGED; OINTMENTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 38349175926     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.34031.x     Document Type: Article

References (23)

1. Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002 47 : 743 8.
2. Wayte DM, Helwig EB. Melanotic freckle of Hutchinson. Cancer 1968 21 : 893 911.
3. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987 116 : 303 10.
4. Stevenson O, Ahmed I. Lentigo maligna: prognosis and treatment options. Am J Clin Dermatol 2005 6 : 151 64.
5. Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol 2004 140 : 552 8.
6. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg 1998 24 : 673 7.
7. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994 31 : 79 85.
8. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997 37 (Pt 1) : 236 45.
9. Sauder DN. Imiquimod: modes of action. Br J Dermatol 2003 149 (Suppl 66) : 5 8.
10. Michalopoulos P, Yawalkar N, Bronnimann M, et al. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. Br J Dermatol 2004 151 : 903 6.
11. Borucki U, Metze D. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream. Dermatology 2003 207 : 326 8.
12. Chapman MS, Spencer SK, Brennick JB. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. Arch Dermatol 2003 139 : 943 4.
13. Epstein E. Extensive lentigo maligna clearing with topical imiquimod. Arch Dermatol 2003 139 : 944 5.
14. Kamin A, Eigentler TK, Radny P, et al. Imiquimod in the treatment of extensive recurrent lentigo maligna. J Am Acad Dermatol 2005 52 (Suppl 1) : 51 2.
15. Kupfer-Bessaguet I, Guillet G, Misery L, et al. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation. J Am Acad Dermatol 2004 51 : 635 9.
16. Lorentzen HF, Weismann K. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance]. Ugeskr Laeger 2005 167 : 3696 7.
17. Munoz CM, Sanchez JL, Martin-Garcia RF. Successful treatment of persistent melanoma in situ with 5% imiquimod cream. Dermatol Surg 2004 30 (Pt 2) : 1543 5.
18. Powell AM, Russell-Jones R. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy. J Am Acad Dermatol 2004 50 : 792 6.
19. Swetter SM, Boldrick JC, Jung SY, et al. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005 125 : 685 91.
20. Fleming CJ, Bryden AM, Evans A, et al. A pilot study of treatment of lentigo maligna with 5% imiquimod cream. Br J Dermatol 2004 151 : 485 8.
21. Naylor MF, Crowson N, Kuwahara R, et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 2003 149 (Suppl 66) : 66 70.
22. Powell AM, Russell-Jones R, Barlow RJ. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol 2004 29 : 15 21.
23. Rivers JK, McCarthy WH. No effect of topical tretinoin on lentigo maligna. Arch Dermatol 1991 127 : 129.